Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection - Wikidata - awgldk - TriplyDB

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

http://www.wikidata.org/entity/Q36699786

about

Autoimmune disease triggered by infection with alphaproteobacteria Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development Infection as a cause of type 1 diabetes?Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie.Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.Natural killer T (NKT) cells in autoimmune hepatitis Autoantibodies and liver disease: uses and abuses.Juvenile autoimmune hepatitis: Spectrum of the disease.Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.Review article: autoimmune hepatitis -- current management and challenges.Medullary thymic epithelial cells and central tolerance in autoimmune hepatitis development: novel perspective from a new mouse model.Microbiota—implications for immunity and transplantation.A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis Autoimmune hepatitis: focusing on treatments other than steroids.Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment Autoimmune liver disease: news and perspectives.Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligand.Aetiopathogenesis of autoimmune hepatitis.Pituitary Microsomal Autoantibodies in Patients with Childhood-Onset Combined Pituitary Hormone Deficiency: an Antigen Identification Attempt Current and future treatments of autoimmune hepatitis.Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?Tolerogenic dendritic cells and myeloid-derived suppressor cells: potential for regulation and therapy of liver auto- and alloimmunity.Cutting edge issues in autoimmune hepatitis.Molecular mimicry as a mechanism of autoimmune disease.Autoantibody-negative autoimmune hepatitis.Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.Review article: overlap syndromes and autoimmune liver disease.The overlap syndromes of autoimmune hepatitis.The role of autoantibodies in autoimmune hepatitis type 2.Diagnosis and treatment of adenovirus infection in immunocompromised patients.Pathogen infection as a possible cause for autoimmune hepatitis.Current and prospective pharmacotherapy for autoimmune hepatitis.Targeting apoptosis in autoimmune hepatitis.Mechanisms of tissue injury in autoimmune liver diseases.Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.

P2860

Q24655779-A3B86918-4C01-40CE-A972-DB58DDBA5B7B Q26781761-6519A883-483C-4A8E-9533-E2BD024615A9 Q27026442-9A0BA7FB-EBEC-40A6-9501-1DDC21C669E4 Q28069584-445B491B-323C-4F4B-A68E-91E0572D0106 Q28087726-84708988-130A-4464-A830-1AF1511AE0FA Q31121156-6385402E-5D48-4293-8ED2-4EFD6D3938CF Q33419380-1C905C33-3941-4322-9535-AD9652905A9A Q33447479-17D5189F-93E9-41FE-A5C2-CA53E3AEA829 Q33580295-F48A75CF-A6E6-4D56-AE24-5C38BC6B0E3E Q33829963-6BD0F162-077F-49E8-B079-3E2BAB6BCD66 Q33948215-7E3C0149-DF38-40C1-A0E7-458090FB04E8 Q33977201-1C8922C5-9B4C-44DB-9132-E21F65604E5C Q34369116-D6E6D123-746A-448F-A79B-36CAE709766C Q35016702-3D965327-C9CB-4DDB-B7F2-E586BF3E52B8 Q35627459-27D5ED50-5D7F-4070-97F5-E015934D833A Q35694206-062E7901-B42A-47C4-A26C-1D6A32B852B4 Q35725777-6A59363E-C605-4794-A368-DFEC0AEDCEF1 Q36231841-66D1901B-70D2-4272-A94E-20E00AB679BC Q36466018-5E8866C0-D10A-477D-B6F0-500172378BE1 Q37002739-304563B6-19DF-4E6A-8293-060BB8AA27E8 Q37058457-D32FBE48-3032-42BE-9FC0-FB00DDF7053B Q37135360-BB0CE37C-A3E9-4A90-97AA-723783FC0F9B Q37182932-681CDA6A-6549-4247-9965-DBA9B12B6BE5 Q37377805-0E5DC682-ED5F-45A8-8A0A-5882F5C49A74 Q37503380-8554EC96-F6F3-4096-AC11-56896F5DE773 Q37588932-FCE9346C-8AF0-4F2E-A045-6545A07B740A Q37770271-94B81534-793A-480E-AAD9-6020448527B6 Q37826110-295558E4-9A71-4DB4-AD0A-78B9987653CE Q37957762-B3C7371D-D446-484C-BBC8-F09C78B9C4EE Q37970311-5CA77DB3-7418-4DA7-B75A-EA569A8E8C7B Q38007886-CE3AE09A-BCA3-41C4-B6D4-E26EC37CD579 Q38027909-F0132672-9EEB-4F1F-8772-051E418FA7DF Q38037392-4D16D4D8-B1E1-468F-9889-6D7F622C28D7 Q38085031-4272B371-9B43-45D9-9BCA-450ACCD0DFE5 Q38145327-CA9ACD6E-FC38-4C54-A685-15B13DE5E189 Q38218770-62B97623-60CE-4730-87D6-4B9034B01339 Q38222882-FB7DC22B-8066-4B82-9AF7-2A5AC503059E Q38231217-B6D37247-95BF-4324-902F-6A08741CCC7B Q38235918-7FF080EE-458B-4FEF-812C-64E014DC9CA0 Q38238921-CA1137E4-08EE-4AD3-8C9E-599A22D3AF46

P2860

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

http://www.wikidata.org/entity/Q36699786

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Breaking tolerance to the natu ...... me P450 2D6 by virus infection

@ast

Breaking tolerance to the natu ...... me P450 2D6 by virus infection

@en

type

label

Breaking tolerance to the natu ...... me P450 2D6 by virus infection

@ast

Breaking tolerance to the natu ...... me P450 2D6 by virus infection

@en

prefLabel

Breaking tolerance to the natu ...... me P450 2D6 by virus infection

@ast

Breaking tolerance to the natu ...... me P450 2D6 by virus infection

@en

P1433

Q36699786-30B65FF0-29B2-41A3-A85D-07AFFD99CDDF

P1476

Q36699786-AE8879E9-279C-43E8-9F6C-E9CB502F7149

P2093

Q36699786-17165838-3F62-47F9-B4A2-09C717B9ED64

Q36699786-2337CA2B-2351-4318-8176-E94496D5FA08

Q36699786-55C55B2A-CD90-4593-A095-929633CF53D8

Q36699786-83B79863-DE34-4715-BB8E-DD2760E1BE19

Q36699786-9A08A152-483C-4F08-9185-55CAE7ABEFC1

Q36699786-A0D7FCFC-EBD8-45C9-AE99-D8143AFF145C

Q36699786-A4ABB2EA-8D03-46BF-A4C2-CD36D5CFAF88

Q36699786-BDFCA68B-E175-4B79-8213-DA5A0CC90891

Q36699786-C3D713E9-6679-426B-A80D-C1B3148DC21D

Q36699786-C977051A-13C0-4037-9ECD-4537C21F6685

P2860

Q36699786-0FCD1BAD-5B22-4C4D-9671-7D2A5658853F

Q36699786-122BCFD5-21E4-48E9-B1AF-E051543E1121

Q36699786-14750CEB-C3CA-4F0C-B4BB-F5B1A2ED97B0

Q36699786-1A5267A8-37BC-435B-8BF9-652562E48E76

Q36699786-2330006F-64C6-4CB8-AF9A-A3157E9255E2

Q36699786-244E8392-AC80-49D1-B755-3CD5BA237AC0

Q36699786-2E69BA06-A195-47BA-B339-8E15AB5252DF

Q36699786-344C3541-F281-4D64-A34B-34F68FF1F10F

Q36699786-4494687E-F0EC-4AF9-98E8-125DA096382E

Q36699786-4859BC7B-E75E-4860-A64B-BA94183AEBCD

P304

Q36699786-A007AF04-144A-4741-AE15-959EB1F12B15

P31

Q36699786-4549C283-2027-44F0-AC3C-006D6A3348EE

P356

Q36699786-B00DB270-2B0F-49F6-9E9D-179BB3CF74E2

P407

Q36699786-6A9D5C54-5474-4EC6-A3D7-5E14CBD5DE78

P433

Q36699786-FD1E6F05-E54B-4AAA-89CC-C4B5B58128BE

P478

Q36699786-2883D94C-4477-4EB8-BFBF-FFA037F6ECE4

P50

Q36699786-19667036-367D-47F6-98A0-D9A758FE993B

P577

Q36699786-958160BA-512F-419E-92F5-6FB1A437AC3E

P5875

Q36699786-769F4354-861D-4513-BBC6-C6058C0D91D8

P698

Q36699786-E2CA8448-A898-4DC9-934B-42F4B58B146E

P932

Q36699786-2C4E917A-0B7C-4F1E-BC26-9A1A469C3D2D

P356

P1433

Journal of Experimental Medicine

P1476

Breaking tolerance to the natu ...... me P450 2D6 by virus infection

@en

P2093

Antje Rhode

http://www.w3.org/2001/XMLSchema#string

Edith Hintermann

http://www.w3.org/2001/XMLSchema#string

Eric F Johnson

http://www.w3.org/2001/XMLSchema#string

Evelyn Rodrigo

http://www.w3.org/2001/XMLSchema#string

Frank J Gonzalez

http://www.w3.org/2001/XMLSchema#string

Gudrun Hintereder

http://www.w3.org/2001/XMLSchema#string

Josef Pfeilschifter

http://www.w3.org/2001/XMLSchema#string

Martin Holdener

http://www.w3.org/2001/XMLSchema#string

Matthias von G Herrath

http://www.w3.org/2001/XMLSchema#string

Michael P Manns

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease

Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition

Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.

LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?

Autoimmune hepatitis, from mechanisms to therapy.

Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Molecular mimicry: a critical look at exemplary instances in human diseases.

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

Bacteria and human autoimmunity: the case of primary biliary cirrhosis.

P304

1409-1422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20071859

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

205

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5376200

http://www.w3.org/2001/XMLSchema#string

P698

18474629

http://www.w3.org/2001/XMLSchema#string

P932

2413037

http://www.w3.org/2001/XMLSchema#string